Utility-adjusted analysis of the cost of palliative radiotherapy for bone metastases

Australasian Radiology

Volumn 47, Issue 3, 2003, Pages 274-278

  Barton, Michael B ^a   Jacob, Susannah A ^a   Gebsky, Val ^b  

^a Liverpool Health Service   (Australia)

^b NONE

Author keywords

Bone metastases; Cost utility analysis; Palliative radiotherapy

Indexed keywords

ARTICLE; BONE METASTASIS; CANCER SURVIVAL; CANCER THERAPY; CONTROLLED STUDY; COST OF ILLNESS; COST UTILITY ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; PALLIATIVE THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION RESPONSE; TREATMENT OUTCOME;

AUSTRALIA; BONE NEOPLASMS; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; HUMANS; PALLIATIVE CARE;

EID: 0141762687     PISSN: 00048461     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1673.2003.01175.x     Document Type: Article

References (24)

1. Stjernsward J. WHO cancer pain relief programme. Cancer Surv 1988; 7: 195-208.
2. Steenland E, Leer J, Van-Houwelingen H et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 1999; 52: 101-9.
3. Tong D, Gillick L, Hendrickson FR. The palliation of symptomatic osseous metastases. The final results of the study by the Radiation Therapy Oncology Group. Cancer 1982; 50: 893-9.
4. The Bone Pain Trial Working Party. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Radiother Oncol 1999; 52: 111-21.
5. Price P, Hoskin PJ, Easton D, Austin D, Palmer SG, Yarnold JR. Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol 1986; 6: 247-55.
6. Okawa T, Kita M, Goto M, Nishijima H, Miyaji N. Randomised prospective clinical study of small, large and twice-a-day fraction radiotherapy for painful bone metastases. Radiother Oncol 1988; 13: 99-104.
7. Hoskin PJ, Price P, Easton D et al. A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain. Radiother Oncol 1992; 23: 74-8.
8. Arcangeli G, Giovinazzo G, Saracino B, D'Angelo L. Radiation therapy in the management of symptomatic bone metastases, the effect of total dose and histology on pain relief and response duration. Int J Radiat Oncol Biol Phys 1998; 42: 1119-26.
9. Gaze MN, Kelly CG, Kerr GR et al. Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules. Radiother Oncol 1997; 45: 109-16.
10. Hoegler D. Radiotherapy for palliation of symptoms in incurable cancer. Curr Prob Cancer 1997; 21: 129-83.
11. Swedish Council on Technology Assessment in Health Care. A prospective survey of radiotherapy in Sweden. Acta Oncol 1996; 35: 1-152.
12. Glazebrook GA. Radiation therapy: a long term cost benefit analysis in a North American region. Clin Oncol 1992; 4: 302-5.
13. Barton MB, Gebski V, Manderson C, Langlands AO. Radiation therapy: are we getting value for money? Clin Oncol 1995; 7: 287-92.
14. Kaplan ES, Meier PJ. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
15. Curtis FG, Wheatley PO. Applied Numerical Analysis, 3rd edn. Addison-Wesley, Reading, 1984.
16. Hall P, Wilson SR. Two guidelines for bootstrap testing. Biometrics 1991; 47: 757-62.
17. Barton MB, Dawson R, Jacob S, Currow D, Stevens G, Morgan S. Palliative radiotherapy of bone metastases - an evaluation of outcome measures. J Eval Clin Pract 2001; 7: 47-64.
18. Smith RD, Jan S, Shiell A. Efficiency considerations in the expansion of radiation therapy services. Int J Radiat Oncol Biol Phys 1995; 31: 379-85.
19. Goodwin PJ. Economic factors in cancer palliation - methodologic considerations. Cancer Treat Rev 1993; 19 (Suppl. A): 59-65.
20. Stevens G, Firth I. Audit in radiation therapy, long-term survival and cost of treatment. Australas Radiol 1997; 41: 29-34.
21. Macklis RM, Cornelli H, Lasher J. Brief courses of palliative radiotherapy for metastatic bone pain. A pilot cost-minimisation comparison with narcotic analgesics. Am J Clin Oncol 1998; 21: 617-22.
22. Rees GJ. Cost-effectiveness in oncology. Lancet 1985; 2: 1405-8.
23. Ferrell BR, Griffith H. Cost issues related to pain management: report from the cancer pain panel of the agency for health care policy and research. J Pain Symptom Manage 1994; 9: 221-34.
24. Hillner BE, Weeks JC, Desch CE, Smith TJ. Pamidronate in prevention of bone complications in metastatic breast cancer: a cost-effectiveness analysis. J Clin Oncol 2000; 18: 72-9.